PAPER
Chiral Bipyridine and Terpyridine Ligands
1669
N,O-Dibenzoyl-3-Iodo-L-tyrosine Methyl Ester (4)
This compound was prepared by following the procedure described
above for 3 using 2 (200 mg, 0.56 mmol) in CH2Cl2 (40 mL), Et3N
(0.468 mL, 3.356 mmol) and benzoyl chloride (0.064 mL, 0.56
mmol). The mixture was stirred at r.t. for 8 h. Purification was per-
formed by chromatography on alumina eluting with CH2Cl2 to af-
ford 216 mg of 4 (73%); mp 203–204 °C; [ ]D +17 (5 g/L in
CH2Cl2).
1H NMR (CDCl3): = 3.28 (m, CH2, 2 H), 3.81 (s, OCH3, 3 H), 5.11
(m, CH, 1 H), 6.71 (d, 3JH-H = 6.9 Hz, 1 H), 7.20 (m, 2 H), 7.52 (m,
5 H), 7.69 (m, 4 H), 8.26 (m, 2 H).
na with CH2Cl2–MeOH (0% to 3%) as eluent to afford 58 mg of 6
(57%); mp 218–219 °C; [ ]D + 37 (c = 5 g/L in CH2Cl2).
1H NMR (CDCl3): = 3.38 (m, CH2, 2 H), 3.79 (s, OCH3, 3 H), 5.12
(m, CH, 1 H), 6.61 (d, 3JH-H = 7.3 Hz, 1 H), 7.08 (m, 3 H), 7.47 (m,
4 H), 7.80 (m, 4 H), 8.22 (dd, 3JH-H = 8.5 Hz, 4JH-H = 2.2 Hz, 1 H),
8.47 (td, 3JH-H = 8.5 Hz, 4JH-H = 2.2 Hz, 2 H), 8.71 (d, 3JH-H = 8.4 Hz,
1 H), 9.15 (m, 1 H).
FT-IR (KBr): = 3280 (s), 3047 (s), 2947 (s), 2915 (s), 2365 (w),
1748 (s), 1649 (s), 1579 (m), 1536 (s), 1459 (m), 1434 (m), 1260
(m), 1230 (s), 1009 (m), 795 cm–1 (m).
UV-Vis (MeCN): max ( , M–1 cm–1) = 336 nm (22,700).
13C{1H} NMR (CDCl3): = 36.8, 52.6, 53.5, 90.4, 123.0, 127.0,
128.6, 128.7, 129.0, 130.3, 130.4, 131.9, 133.7, 133.9, 135.7, 140.2,
150.5, 164.2, 167.0, 171.7.
MS (FAB+): m/z (nature of peak, relative intensity) = 478 ([M + H]+,
100), 419 ([M – CO2CH3 + H]+, 50).
Anal. Calcd for C29H23N3O4 (477.5): C, 72.94; H, 4.85; N, 8.80.
Found: C, 72.62; H, 4.59; N, 8.65.
FT-IR (KBr): = 3328 (s), 2944 (m), 2362 (w), 1733 (s), 1638 (s),
1602 (w), 1578 (w), 1527 (s), 1487 (m), 1449 (m), 1373 (m), 1320
(m), 1260 (s), 1203 (s), 1160 (m), 1081 (m), 705 cm–1 (m).
UV-Vis (CH2Cl2): max ( , M–1 cm–1) = 269 nm (3,500).
Ligand 7
This ligand was prepared according to the general procedure, start-
ing from a solution of 4 (100 mg, 0.189 mmol) in THF (8 mL),
4’-ethynyl-2,2’:6’,2’’-terpyridine (58 mg, 0.227 mmol),
Pd(PPh3)2Cl2 (8 mg, 0.011 mmol), CuI (2 mg, 0.011 mmol) and di-
isopropylamine (2 mL). Purification was performed by chromatog-
raphy on alumina with CH2Cl2–MeOH (0% to 10%) as eluent to
give 61 mg of 7 (49%); mp 232–233 °C; [ ]D + 49 (c = 5 g/L in
CH2Cl2).
MS (FAB+): m/z (nature of peak, relative intensity) = 530 ([M + H]+,
100), 426 ([M – PhCO + 2 H]+, 20), 320 ([M – 2 PhCO + H]+, 5).
Anal. Calcd for C24H20INO5 (529.3): C, 54.46; H, 3.82; N, 2.65.
Found: C, 54.15; H, 3.62; N, 2.47.
Ligands 5–7; General Procedure
A Schlenk flask was charged stepwise with derivatives 3 or 4 and
4’-ethynyl-2,2’:6’,2’’terpyridine or 5-ethynyl-2,2’-bipyridine in ar-
gon degassed THF, then with Pd(PPh3)2Cl2 (6 mol%) and CuI (6
mol%) and finally argon degassed diisopropylamine was added.
The mixture was stirred for 3 d at r.t. After consumption of the start-
ing material (followed by TLC), the solvent was evaporated and the
residue was purified by chromatography on alumina using CH2Cl2
with a gradient of MeOH.
1H NMR (CDCl3): = 3.23 (m, CH2, 2 H), 3.82 (s, OCH3, 3 H), 5.11
(m, CH, 1 H), 6.64 (d, 3JH-H = 6.7 Hz, 1 H), 6.92 (d, 3JH-H = 8.3 Hz,
1 H), 7.11 (d, 3JH-H = 8.5 Hz, 1 H), 7.23 (d, 4JH-H = 2.0 Hz, 1 H), 7.41
(m, 10 H), 7.78 (dd, 3JH-H = 7.8 Hz, 4JH-H = 1.7 Hz, 2 H), 7.87 (td,
3JH-H = 7.8 Hz, 4JH-H = 1.7 Hz, 2 H), 8.53 (s, 2 H), 8.60 (d, 3JH-H
=
7.8 Hz, 2 H), 8.73 (m, 2 H).
FT-IR (KBr): = 3272 (m), 3058 (w), 2954 (m), 2923 (s), 2851 (m),
2211 (w), 1739 (s), 1637 (m), 1576 (s), 1488 (m), 1465 (s), 1391 (s),
1262 (s), 1215, (m), 1177 (m), 891 (w), 792 cm–1 (s).
Ligand 5
This ligand was prepared according to the general procedure, start-
ing from a solution of 3 (110 mg, 0.258 mmol) in THF (10 mL), 4’-
ethynyl-2,2’:6’,2’’-terpyridine (80 mg, 0.310 mmol), Pd(PPh3)2Cl2
(10 mg, 0.014 mmol), CuI (3 mg, 0.016 mmol) and diisopropy-
lamine (3 mL). Purification was performed by chromatography on
alumina with CH2Cl2–MeOH (0% to 4%) as eluent and afforded 60
mg of 5 (42%); mp 224–225 °C; [ ]D + 41 (5 g/L in CH2Cl2).
1H NMR (CDCl3): = 3.37 (m, CH2, 2 H), 3.79 (s, OCH3, 3 H), 5.12
(m, CH, 1 H), 6.72 (d, 3JH-H = 7.8 Hz, 1 H), 7.11 (d, 3JH-H = 8.4 Hz,
1 H), 7.41 (m, 8 H), 7.74 (dd, 3JH-H = 8.0 Hz, 4JH-H = 1.8 Hz, 2 H),
7.86 (td, 3JH-H = 8.0 Hz, 4JH-H = 1.8 Hz, 2 H), 8.62 (dd, 3JH-H = 8.0
Hz, 4JH-H = 0.7 Hz, 2 H), 8.73 (m, 2 H), 8.83 (m, 2 H).
UV-Vis (MeCN):
(37,400).
( , M–1 cm–1) = 288 (55,900), 311 nm
max
MS (FAB+): m/z (nature of peak, relative intensity) = 659 ([M + H]+,
100), 600 ([M – CO2CH3 + H]+, 30), 495 ([M – CO2CH3 – PhCO +
H]+, 10).
Anal. Calcd for C41H30N4O5 (658.7): C, 74.76; H, 4.59; N, 8.51.
Found: C, 74.63; H, 4.42; N, 8.39.
Ruthenium Complexes 8–10; General Procedures
Experimental Condition 1: A stirred solution of Ru(terpy)(DM-
SO)Cl2 (1 equiv) and AgBF4 (2 equiv) in argon degassed MeOH
was heated at 80 °C for 8 h. After cooling to r.t., the deep-red solu-
tion was filtered over cotton-wool and transferred via cannula to a
suspension of the terpy-ligands (1 equiv) in MeOH (3 mL) and the
solution was heated at 80 °C for 2 d. After complete consumption
of the starting material, a solution of KPF6 (5 equiv) in H2O (10 mL)
was added, the organic solvent was than removed under vacuum
and the precipitate was purified by chromatography on alumina
eluting with CH2Cl2 using a gradient of MeOH (0% to 5%). The
pure red-orange compounds were obtained by recrystallization from
CH2Cl2–hexane.
FT-IR (KBr): = 3261 (m), 3057 (m), 2951 (m), 2923 (m), 2854
(m), 1737 (s), 1644 (s), 1608 (s), 1581 (s), 1540 (s), 1466 (s), 1438
(m), 1400 (s), 1347 (w), 1262 (m), 1229 (m), 1121 cm–1 (w).
UV-Vis (MeCN):
(27,900).
( , M–1 cm–1) = 286 (28,200), 317 nm
max
MS (FAB+): m/z (nature of peak, relative intensity) = 555 ([M + H]+,
100), 496 ([M –CO2CH3 + H]+, 20).
Anal. Calcd for C34H26N4O4 (554.6): C, 73.63; H, 4.73; N, 10.10.
Found: C, 73.43; H, 4.42; N, 9.72.
Experimental Condition 2: A stirred solution of Ru(bpy)2Cl2 H2O
(1 equiv) in MeOH and the bipy ligand was heated at 80 °C for 16
h. The pure complex was obtained as described above for com-
pound 1.
Ligand 6
This ligand was prepared according to the general procedure, start-
ing from a solution of 3 (90 mg, 0.212 mmol) in THF (7 mL),
5-ethynyl-2,2’-bipyridine (46 mg, 0.255 mmol), Pd(PPh3)2Cl2 (9
mg, 0.012 mmol), CuI (2.3 mg, 0.012 mmol) and diisopropylamine
(1.5 mL). Purification was performed by chromatography on alumi-
Ruthenium Complex 8
Prepared according to experimental conditions 1, starting from
Ru(terpy)(DMSO)Cl2 (35 mg, 0.07 mmol), AgBF4 (28 mg, 0.14
Synthesis 2001, No. 11, 1665–1670 ISSN 0039-7881 © Thieme Stuttgart · New York